TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ASIC

Ategrity Specialty Insurance Company Holdings

Financial Services · Insurance - Property & Casualty · listed since 2025

28.20$ -0.4% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

The business model visibly works: an expense ratio falling from 33.6 to 27.5 percent since 2024 is not a lucky streak but scaling — and a debt-free balance sheet with $664.4 million of equity, an "A-" rating and catastrophe exposure of 2 percent of equity leaves no room for a substance finding. A red light would require things that simply are not there: no going-concern issue, no breached covenant, no negative cash flow, no listing risk. A green light lacks two proofs. First the reserves: in casualty — two thirds of the book — 3.2 percent of claims are paid after one year, so the 85.9 percent combined ratio is a well-founded estimate until 2031, not a result. Second the closeness to the owner: 80.7 percent held by ZFSG, no compensation or nominating committees, $106.5 million lent to ZFSG subsidiaries, $227.3 million in a fund run by the affiliated manager, and a chief financial officer who is simultaneously chief financial officer of the majority owner. Add distribution concentration of 46.5 percent across three brokers. At 1.8 times book you are already paying for the scaling — it only becomes verifiable with the 2027 to 2031 accident years. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Ategrity Specialty is the ticker trap with a pleasant surprise: behind the chip-sounding ASIC sits a U.S. specialty insurer whose combined ratio has fallen for three years (97.5 to 85.9 percent) and whose premiums grew 23.4 percent to $206.8 million in the second quarter of 2026 — on a debt-free balance sheet with $664.4 million of equity and catastrophe exposure of only 2 percent of equity. Three things stand against that in the filings: only 3.2 percent of casualty claims are paid after the first year, three brokers bring in 46.5 percent of premiums, and $106.5 million of the assets sits as a loan with subsidiaries of the majority owner, who holds 80.7 percent. In the second quarter of 2026 just $16.0 million of $46.4 million in pre-tax income came from insurance itself. Not investment advice.

Underwriting earnings power

The combined ratio fell without interruption from 97.5 percent (2023) through 93.9 (2024) and 88.2 (2025) to 85.9 percent in the second quarter of 2026 — through 2024 driven by the loss ratio (66.6 down to 60.3 percent), since then by an expense ratio that dropped from 33.6 percent (2024) to 27.5 percent. Underwriting income rose 66.9 percent to $16.0 million in the second quarter of 2026 and gross written premiums 23.4 percent to $206.8 million. That is real scaling with 203 employees.

Balance sheet & capital strength

As of June 30, 2026 the books show $664.4 million of stockholders' equity and $1,175.8 million of invested assets with no financial debt whatsoever; the two $35 million letter-of-credit facilities were terminated in 2025 without replacement. Book value per share rose 8.5 percent in six months to $13.86, the estimated net probable maximum loss for a 1-in-250-year event is 2.0 percent of equity, and the A.M. Best rating is "A-" (Excellent) with a positive outlook.

Reserves & track record

The annual report shows no prior-year development for 2025, but $5.4 million for 2024. None of this can be properly tested yet: only 3.2 percent of casualty claims are paid after the first year, and a 7.5 percent deviation in net reserves would move pre-tax income by $27.2 million — 28 percent of 2025 pre-tax income. An in-house reserve committee, the statutory annual actuarial opinion and an independent actuarial firm engaged "periodically" back up the estimates, but the company has only been public since June 12, 2025.

Distribution concentration

Three wholesale brokers accounted for $270.4 million, or 46.5 percent, of gross written premiums in 2025; a year earlier it was one partner at $105.3 million, or 24.1 percent. The dependency almost doubled during the growth phase, and Ategrity sells exclusively through such intermediaries. That is industry practice — it is not protection.

Owner & related-party business

Zimmer Financial Services Group holds 80.7 percent (10-K 2025); as a "controlled company" Ategrity maintains neither a compensation nor a nominating committee. $106.5 million of invested assets sits as a loan with ZFSG subsidiaries ($94.0 million at 5.5 percent through 2032) and $227.3 million in a Cayman fund run by the affiliated manager. The CEO sits on three payrolls inside the owner's orbit, and the chief financial officer appointed on July 9, 2026 is simultaneously chief financial officer of the majority owner.

Earnings quality

Of second-quarter 2026 pre-tax income of $46.4 million, only $16.0 million came from underwriting; $12.7 million was recurring investment income and $18.6 million realized and unrealized investment gains — a line that stood at negative $4.6 million in the first quarter of 2025. Extrapolate $0.67 of quarterly earnings per share and 40 percent of what you are extrapolating is market movement.

Worth Noting

Ticker confusion warning: "ASIC" is a semiconductor term (application-specific integrated circuit) and also the abbreviation of the Australian Securities and Investments Commission. This stock is neither — it is Ategrity Specialty Insurance Company Holdings, a U.S. excess and surplus lines insurer (NYSE, CIK 0002040491).

Ategrity reached our research list through Reddit mentions as of July 30, 2026 — not through one of our momentum or valuation scanners. The company has only been in our data set for a few weeks; our scanner lists are recalculated nightly and showed no hit at the time of this analysis. Classic screening metrics such as price-to-sales or gross margin carry no meaning at an insurer anyway; the load-bearing anchors are the combined ratio, book value per share and return on equity.

Data basis and as-of dates: annual and quarterly figures come from the Form 10-K for 2025 (filed 03/06/2026), the Form 10-Q as of 03/31/2026 and the Form 8-K dated 07/29/2026 (Exhibit 99.1, second quarter 2026 results); the 2023 figures come from the 424B4 IPO prospectus dated 06/11/2025. Price, market capitalization and share count carry a data date of July 30, 2026; the only share price documented in a filing is the closing price of $21.01 on 12/31/2025. Because of the LLC-to-corporation conversion and the 1-for-10.66 reverse split, all per-share figures before June 2025 are restated.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at ASIC since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 16.40 $ to 28.70 $ · Last price: 28.20 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 1.4$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 48m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 18.6%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market.

Performance

Perf. 1M ?Price performance over the last month. 0.30%
Perf. 3M ?Price performance over the last 3 months. 21.60%
Perf. 6M ?Price performance over the last 6 months. 41.90%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). 17.28%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -3.7%
Perf. 1Y ?Price performance over the last 12 months. 36.68%
Perf. Since Inception ?Price performance since the first available trading day (06/11/2025) — with a complete history, that is since the IPO. 14.14%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 25.90$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 25.30$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 21.40$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 64.7
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 29.1%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 46.6%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E. 14.9
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 9.9
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity. 2.2
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 2.7
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 0.0
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 8.3

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 28.4%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 26.6%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 20.7%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 17.9%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 6.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 41.7%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity. 0.0
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. 1.25
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 6 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 55.20%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 155.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 23.41%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. -100.00%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 28.40%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line.
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks.
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth.
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. B (74 out of 100)

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Insurance - Property & Casualty

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Ategrity Specialty Insurance Company Holdings ASIC 1.4 14.9 0.0 28.4 26.6 23.4 36.7
Chubb Ltd CB 132.6 12.7 0.0 31.1 20.6 6.5 27.1
Progressive Corp PGR 126.0 11.7 21.9 18.5 16.4 16.3 -5.5
The Travelers Companies Inc TRV 79.1 11.7 0.0 34.7 18.7 5.2 40.1
The Allstate Corporation ALL 64.9 5.9 0.0 36.8 19.0 4.6 30.3
W. R. Berkley Corp WRB 26.1 15.4 0.0 43.8 17.1 7.8 -1.5
Cincinnati Financial Corporation CINF 25.8 10.1 0.0 31.1 11.8 11.4 13.9
Markel Corporation MKL 21.9 13.2 0.0 51.9 -9.7 -1.0 -7.4
Loews Corp L 21.8 14.2 0.0 36.3 11.8 5.4 12.2
Median of companies shown 26.1 12.7 0.0 34.7 17.1 6.5 13.9

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2023 · Revenue: 241 $M 2023 · Operating income: 13 $M 2023 · Net income: 10 $M 2024 · Revenue: 344 $M 2024 · Operating income: 66 $M 2024 · Net income: 47 $M 2025 · Revenue: 424 $M 2025 · Operating income: 96 $M 2025 · Net income: 74 $M
202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2023 241 13 10 0.21 126 322 882
2024 344 66 47 0.97 126 398 1,123
2025 424 96 74 1.60 147 614 1,474

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2025: Q1 · 83.1 $M Q1 2025: Q2 · 101.8 $M Q2 2025: Q3 · 116.1 $M Q3 2025: Q4 · 123.3 $M Q4 2026: Q1 · 129.0 $M Q1 2026: Q2 · 148.5 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2025: Q1 0.02 83 9.30 10.20 21 21
2025: Q2 0.39 102 34.40 17.30 30 30
2025: Q3 0.45 116 28.60 19.50 41 40
2025: Q4 0.51 123 22.80 20.50 55 49
2026: Q1 0.51 2,450.00 129 55.20 19.70 42 42
2026: Q2 0.67 71.80 149 45.90 22.60 39 38

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 7 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Research

Value & GARP

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus
Analyst Ratings
Price Target (average) 29.10$
Distance to price 3.2% The price target sits 3.2% above the current price.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 2.25 2.23 – 2.29 543 39.8% 4
12/31/2027 2.52 2.40 – 2.70 680 11.9% 5

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly -4.6% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $170.0M
Market cap $1.41B
Free cash flow in year ten $106.7M
Terminal value as a share of market value 39.9%

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Uses AI

Ategrity setzt KI-gestützte Analytik und Automatisierung im eigenen Betrieb ein — eigene Governance-Prozesse für neue KI-Anwendungsfälle, automatisierte Eignungsprüfung und Bepreisung im Kleingeschäfts-Kanal sowie KI-gestützte Zeichnungs- und Schadenentscheidungen unter menschlicher Aufsicht (Geschäftsbericht 10-K für 2025, Item 1 „Technology“ und Item 1A „Risk Factors“). KI ist dabei keine Umsatzquelle: Die Erlöse stammen ausschließlich aus Prämien des Excess-and-Surplus-Lines-Geschäfts.

View the full file — quotes, sources, reviewed filings
„We have implemented governance processes designed to oversee the development, deployment and monitoring of AI-enabled tools and data analytics used in our operations. These processes include protocols for new AI use cases, human review and oversight of underwriting and claims decisions informed by automated tools, model validation procedures, and periodic performance monitoring."

Wir haben Governance-Prozesse eingeführt, die die Entwicklung, den Einsatz und die Überwachung von KI-gestützten Werkzeugen und Datenanalysen in unserem Betrieb beaufsichtigen sollen. Zu diesen Prozessen gehören Vorgaben für neue KI-Anwendungsfälle, menschliche Prüfung und Aufsicht über Zeichnungs- und Schadenentscheidungen, die auf automatisierten Werkzeugen beruhen, Verfahren zur Modellvalidierung und eine regelmäßige Leistungsüberwachung.

10-K · 2026-03-06 · View SEC filing

„Our increasing use of AI-enabled analytics and automated decision-support tools may introduce additional complexity and uncertainty into our modeling framework."

Unser zunehmender Einsatz von KI-gestützter Analytik und automatisierten Werkzeugen zur Entscheidungsunterstützung kann zusätzliche Komplexität und Unsicherheit in unser Modellierungsrahmenwerk hineintragen.

10-K · 2026-03-06 · View SEC filing

„In our Small Business channel, our cloud-based engine enables automated eligibility screening, pricing and documentation generation for standardized risks."

In unserem Kleingeschäfts-Kanal ermöglicht unsere cloudbasierte Engine eine automatisierte Eignungsprüfung, Bepreisung und Dokumentenerstellung für standardisierte Risiken.

10-K · 2026-03-06 · View SEC filing

Filings Reviewed: 10-K 2026-03-06 · 10-Q 2026-05-07 · 8-K 2026-07-29 · 10-Q 2025-11-12 · 10-Q 2025-08-14 · 424B4 2025-06-11

Rated on July 30, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

7 of 10 Solid growth
  • Revenue grows by more than 15% a year over three years no data
  • More than 10% revenue growth is expected for the coming year -100.0%
  • Share count grows by less than 3% a year no data
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 56.6%
  • Gross margin at 40% or higher and without meaningful erosion 50.0%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 273 m net cash
  • Operating cash flow covers the profits of the last three years 267 m
  • Return on capital at 15% or higher, or up versus two years ago 15.5%
  • Insiders hold at least 10% or are net buyers 81.2%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

5/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5%
  • Exp. sales growth 3Y > 5% 26.6%
  • EBIT growth 10Y > 5%
  • Exp. EBIT growth 3Y > 5% 25.5%
  • Net debt < 4x EBIT -2.8x
  • EBIT positive, 10Y straight
  • Max. EBIT decline < 50%
  • Return on equity > 15% 12.7%
  • ROCE > 15% 15.5%
  • Expected return > 10% 38.0%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

The company

About the Company

Ategrity Specialty Insurance Company Holdings, through its subsidiaries, provides excess and surplus lines insurance and reinsurance products to small and medium-sized businesses in the United States. The company offers property and casualty insurance solutions, including general liability, commercial property, management liability, miscellaneous PL, allied healthcare, and architects and engineers insurance products to the retail, real estate, hospitality, and construction sectors. It markets and distributes its products through brokerage and small business channels. The company was formerly known as Ategrity Specialty Holdings LLC and changed its name to Ategrity Specialty Insurance Company Holdings in June 2025. Ategrity Specialty Insurance Company Holdings was incorporated in 2017 and is based in New York, New York. Ategrity Specialty Insurance Company Holdings operates as a subsidiary of Zimmer Financial Services Group LLC.

Employees
203
Headquarters
New York, NY
Address
9 West 57th Street, 10019 New York, United States
Phone
212 509 1699
IPO Date
06/11/2025
ISIN
US04681Y1038

Management

Management
Name Title Birth Year
Justin G. Cohen CEO & Director 1975
Chris Schenk President & Chief Underwriting Officer 1982

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/04/2026 Ategrity Specialty Insurance Co Holdings (ASIC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers SEC ↗
  • 07/29/2026 Ategrity Specialty Insurance Co Holdings (ASIC): Results of Operations and Financial Condition SEC ↗
  • 07/10/2026 Ategrity Specialty Insurance Co Holdings (ASIC): Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?